VeriMomSollte ich ci 77947 in der Schwangerschaft meiden? | VeriMom
Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
ECHA regulatory hazard statements
- •H400
- •H410
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist ci 77947 in der Schwangerschaft sicher?
- Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
- Ist ci 77947 während des Stillens sicher?
- Because dermal/systemic absorption of zinc oxide from topical formulations is negligible under normal use (per SCCS/CIR assessments), maternal systemic exposure that could transfer to breast milk is not expected. No authoritative evidence of reproductive/lactational toxicity from harmonised classifications.
- Ist ci 77947 sicher für Babyhaut?
- Hazard and mechanism: no infant-specific reproductive/toxic mechanism identified. Exposure: while adult dermal absorption is negligible, zinc oxide is not absolutely non-absorbable and infants (0–3 yr) have an immature skin barrier/higher surface‑area‑to‑body‑weight, so exposure score is increased by +1 relative to adults. SCCS/CIR accept topical use (including in sunscreens and barrier creams) given minimal systemic uptake, but infant-specific absorption data are limited.
- Wie bewertet VeriMom ci 77947?
- VeriMom bewertet ci 77947 mit 39/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu ci 77947?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu ci 77947 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.